Showing results (681-690 of 719) with videos related to

Sort By:
Pageof 72
Kardiologia Polska|May 14, 2023
Pharmacotherapy of heart failure A.D. 2023. Expert opinion of Working Group on Cardiovascular Pharmacotherapy, Polish Cardiac SocietyJarosław D Kasprzak, Iwona Gorczyca-Głowacka, Maria Sobczak-Kaleta, et al.
Archives of Medical Science : AMS|December 7, 2023
Risk of left atrial appendage thrombus in older patients with atrial fibrillationMonika Gawałko, Monika Budnik, Beata Uziębło-Życzkowska, et al.
Pediatric Obesity|September 2, 2022
A randomized trial comparing diet and delivery strategies for weight management in adolescents with intellectual disabilitiesLauren T Ptomey, Richard A Washburn, Jeannine R Goetz, et al.
Cardiology Research and Practice|October 5, 2020
Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and RivaroxabanIwona Gorczyca, Magdalena Chrapek, Olga Jelonek, et al.
Cardiology Journal|March 25, 2020
Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney diseaseMonika Budnik, Monika Gawałko, Iwona Gorczyca, et al.
Cardiovascular Therapeutics|May 16, 2020
Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial FibrillationBeata Uziębło-Życzkowska, Paweł Krzesiński, Agnieszka Jurek, et al.
Blood|April 19, 2011
Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemiaWilliam G Wierda, Thomas J Kipps, Jan Dürig, et al.
Leukemia & Lymphoma|January 20, 2016
Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemiaAnders Österborg, Miklós Udvardy, Andrey Zaritskey, et al.
Journal of Cardiovascular Electrophysiology|May 28, 2020
Thrombus in the left atrial appendage in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants in clinical practice-A multicenter registryIwona Gorczyca, Anna Michalska, Magdalena Chrapek, et al.
Medicine|June 23, 2020
Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?Anna Michalska, Iwona Gorczyca, Magdalena Chrapek, et al.
Pageof 72